{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:33:47Z","timestamp":1776306827649,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.exppara.2022.108250","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:41:01Z","timestamp":1649036461000},"page":"108250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection"],"prefix":"10.1016","volume":"236-237","author":[{"given":"Rajan Kumar","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupal","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moodu","family":"Devender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prince","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhulika","family":"Namdeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bajarang Vasant","family":"Kumbhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radheshyam","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-0596","authenticated-orcid":false,"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2022.108250_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/1791-809X.1000519","article-title":"Leishmaniasis: a review on parasite, vector and reservoir host","volume":"11","author":"Alemayehu","year":"2017","journal-title":"Health Sci. J."},{"key":"10.1016\/j.exppara.2022.108250_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/092986609787316306","article-title":"Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis","volume":"16","author":"Baiocco","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.exppara.2022.108250_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-3156.2009.02279.x","article-title":"The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India","volume":"14","author":"Boelaert","year":"2009","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2022.108250_bib4","series-title":"Mechanism of Action of Amphotericin B at the Cellular Level. Its Modulation by Delivery Systems","author":"Bolard","year":"1993"},{"issue":"Suppl. l","key":"10.1016\/j.exppara.2022.108250_bib5","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s002800051114","article-title":"Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma","volume":"44","author":"Clive","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.exppara.2022.108250_bib6","first-page":"183","article-title":"Studies in human malaria. XXV. Trial of febrifugine, an alkaloid obtained from Dichroa febrifuga lour., against the Chesson strain of Plasmodium vivax","volume":"9","author":"Coatney","year":"1950","journal-title":"J. Natl. Malar. Soc."},{"key":"10.1016\/j.exppara.2022.108250_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1432-1033.1995.tb20583.x","article-title":"Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials","volume":"230","author":"Cunningham","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.exppara.2022.108250_bib8","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.166.6.4020","article-title":"Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response","volume":"166","author":"Das","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2022.108250_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2022.108250_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.579891","article-title":"Use of natural products in leishmaniasis chemotherapy: an overview","volume":"8","author":"Gervazoni","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.exppara.2022.108250_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exppara.2022.108250_bib12","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1021\/jm0302086","article-title":"Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite","volume":"46","author":"Hirai","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108250_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/qsar.200730051","article-title":"Benchmarking the reliability of QikProp. Correlation between experimental and predicted values","volume":"27","author":"Ioakimidis","year":"2008","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.exppara.2022.108250_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/AAC.49.3.1169-1176.2005","article-title":"Antimalarial activities and therapeutic properties of febrifugine analogs","volume":"49","author":"Jiang","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108250_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/273595a0","article-title":"Epidemiology and ecology of leishmaniasis in Latin-America","volume":"273","author":"Lainson","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2022.108250_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/biom10030426","article-title":"Plant-based natural products for the discovery and development of novel anthelmintics against nematodes","volume":"10","author":"Liu","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.exppara.2022.108250_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2915.2012.01034.x","article-title":"Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern","volume":"27","author":"Maroli","year":"2013","journal-title":"Med. Vet. Entomol."},{"key":"10.1016\/j.exppara.2022.108250_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570163043484789","article-title":"Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data","volume":"1","author":"Matthews","year":"2004","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.exppara.2022.108250_bib19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JCM.01733-09","article-title":"Evaluation of blood agar microtiter plates for culturing <em>Leishmania<\/em> parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis","volume":"48","author":"Maurya","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.exppara.2022.108250_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/cid\/cit588","article-title":"Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis","volume":"57","author":"Messori","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2022.108250_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0006-2952(99)00244-0","article-title":"Potentiation by febrifugine of host defense in mice against plasmodium berghei NK65","volume":"58","author":"Murata","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2022.108250_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0959-8049(05)80142-X","article-title":"Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer","volume":"29","author":"Planting","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exppara.2022.108250_bib23","first-page":"477","article-title":"Further results of the experimental treatment of trypanosomiasis: being a progress report to a committee of the royal society","volume":"80","author":"Plimmer","year":"1908","journal-title":"Proc. R. Soc. Lond. - Ser. B Contain. Pap. a Biol. Character"},{"key":"10.1016\/j.exppara.2022.108250_bib24","first-page":"505","article-title":"A preliminary summary of the results of the experimental treatment of Trypanosomiasis in rats","volume":"79","author":"Plimmer","year":"1907","journal-title":"Proc. R. Soc. Lond. - Ser. B Contain. Pap. a Biol. Character"},{"key":"10.1016\/j.exppara.2022.108250_bib25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bbapap.2009.06.017","article-title":"Leishmania donovani trypanothione reductase: role of urea and guanidine hydrochloride in modulation of functional and structural properties","volume":"1794","author":"Rai","year":"2009","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.exppara.2022.108250_bib26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bbapap.2009.06.017","article-title":"Leishmania donovani trypanothione reductase: role of urea and guanidine hydrochloride in modulation of functional and structural properties","volume":"1794","author":"Rai","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exppara.2022.108250_bib27","first-page":"67","article-title":"Exploring the antiparasitic activity OF medicinal plants","volume":"5","author":"Raoof","year":"2020","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.exppara.2022.108250_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reim\u00e3o","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2022.108250_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cmdc.200900097","article-title":"Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis","volume":"4","author":"Richardson","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.exppara.2022.108250_bib30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2022.108250_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/acs.molpharmaceut.6b01034","article-title":"Engineering oral and parenteral amorphous amphotericin B formulations against experimental trypanosoma cruzi infections","volume":"14","author":"Rolon","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.exppara.2022.108250_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108250_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"Samant","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2022.108250_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2022.108250_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12539-013-0147-z","article-title":"Docking and in silico ADMET studies of noraristeromycin, curcumin and its derivatives with Plasmodium falciparum SAH hydrolase: a molecular drug target against malaria","volume":"5","author":"Singh","year":"2013","journal-title":"Interdiscip. Sci."},{"key":"10.1016\/j.exppara.2022.108250_bib36","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exppara.2022.108250_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2022.108250_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ. global. health."},{"key":"10.1016\/j.exppara.2022.108250_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0166-6851(94)00034-4","article-title":"The structure, organization, and expression of the Leishmania donovani gene encoding trypanothione reductase","volume":"64","author":"Taylor","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2022.108250_bib40","article-title":"Distribution of human leishmaniasis (VL) and its associated risk factors, in metemma, Ethiopia","volume":"5","author":"Terefe","year":"2015","journal-title":"Epidemiol. Res. Int."},{"key":"10.1016\/j.exppara.2022.108250_bib41","first-page":"26","article-title":"Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis","volume":"18","author":"Tiwari","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.exppara.2022.108250_bib42","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.exppara.2022.108250_bib43","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1073\/pnas.95.9.5311","article-title":"Down-regulation of <em>Leishmania donovani<\/em> trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival","volume":"95","author":"Tovar","year":"1998","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:30:05Z","timestamp":1758004205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489422000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"alternative-id":["S0014489422000443"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108250","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108250"}}